These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3732274)

  • 1. Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from kappa-casein on platelet function.
    Jollès P; Lévy-Toledano S; Fiat AM; Soria C; Gillessen D; Thomaidis A; Dunn FW; Caen JP
    Eur J Biochem; 1986 Jul; 158(2):379-82. PubMed ID: 3732274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologically active peptides of casein and lactotransferrin implicated in platelet function.
    Fiat AM; Levy-Toledano S; Caen JP; Jollès P
    J Dairy Res; 1989; 56(3):351-5. PubMed ID: 2760301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of kappa-casein split peptides on platelet aggregation and on thrombus formation in the guinea-pig.
    Bal dit Sollier C; Drouet L; Pignaud G; Chevallier C; Caen J; Fiat AM; Izquierdo C; Jolles P
    Thromb Res; 1996 Feb; 81(4):427-37. PubMed ID: 8907292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
    Huang TF; Wang WJ; Teng CM; Ouyang C
    Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
    Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid antagonist peptides derived from kappa-casein.
    Chiba H; Tani F; Yoshikawa M
    J Dairy Res; 1989; 56(3):363-6. PubMed ID: 2760302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the cell adhesion peptide, Arg-Gly-Asp-Ser, on responses of washed platelets from humans, rabbits, and rats.
    Harfenist EJ; Packham MA; Mustard JF
    Blood; 1988 Jan; 71(1):132-6. PubMed ID: 3334894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline.
    Plow EF; Marguerie G
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3711-5. PubMed ID: 6954514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet "hybrid" peptides analogous to receptor recognition domains on gamma and alpha chains of human fibrinogen.
    Timmons S; Bednarek MA; Kloczewiak M; Hawiger J
    Biochemistry; 1989 Apr; 28(7):2919-23. PubMed ID: 2742820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral contraceptives, or lanosterol, on ADP-induced aggregation and binding of 125I-fibrinogen to rat platelets.
    McGregor L; Toor B; McGregor JL; Renaud S; Clemetson KJ
    Thromb Res; 1984 Mar; 33(5):517-22. PubMed ID: 6719398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic inhibition of platelet aggregation by fibrinogen-related peptides.
    Adelman B; Gennings C; Strony J; Hanners E
    Circ Res; 1990 Oct; 67(4):941-7. PubMed ID: 2208617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADP-stimulated fibrinogen binding is necessary for some of the inositol phospholipid changes found in ADP-stimulated platelets.
    Vickers JD
    Eur J Biochem; 1993 Aug; 216(1):231-7. PubMed ID: 8396029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that a collagen derived octapeptide inhibits fibrinogen binding to platelets stimulated by collagen and not by ADP.
    Pintigny D; Legrand C; Karniguian A; Legrand YJ; Caen JP
    Biochem Biophys Res Commun; 1985 Apr; 128(2):547-53. PubMed ID: 3994711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
    Timmons S; Kloczewiak M; Hawiger J
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo degradation of human fibrinogen A alpha: detection of cleavage sites and release of antithrombotic peptides.
    Ständker L; Sillard R; Bensch KW; Ruf A; Raida M; Schulz-Knappe P; Schepky AG; Patscheke H; Forssmann WG
    Biochem Biophys Res Commun; 1995 Oct; 215(3):896-902. PubMed ID: 7488058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.